The Simultaneous Detection of Dopamine and Uric Acid In Vivo Based on a 3D Reduced Graphene Oxide–MXene Composite Electrode

Lingjun Shang,Ruijiao Li,Haojie Li,Shuaiqun Yu,Xuming Sun,Yi Yu,Qiongqiong Ren

DOI: https://doi.org/10.3390/molecules29091936

IF: 4.6

2024-04-24

Molecules

Abstract:Dopamine (DA) and uric acid (UA) are essential for many physiological processes in the human body. Abnormal levels of DA and UA can lead to multiple diseases, such as Parkinson's disease and gout. In this work, a three-dimensional reduced graphene oxide–MXene (3D rGO-Ti3C2) composite electrode was prepared using a simple one-step hydrothermal reduction process, which could separate the oxidation potentials of DA and UA, enabling the simultaneous detection of DA and UA. The 3D rGO-Ti3C2 electrode exhibited excellent electrocatalytic activity towards both DA and UA. In 0.01 M PBS solution, the linear range of DA was 0.5–500 μM with a sensitivity of 0.74 μA·μM−1·cm−2 and a detection limit of 0.056 μM (S/N = 3), while the linear range of UA was 0.5–60 μM and 80–450 μM, with sensitivity of 2.96 and 0.81 μA·μM−1·cm−2, respectively, and a detection limit of 0.086 μM (S/N = 3). In 10% fetal bovine serum (FBS) solution, the linear range of DA was 0.5–500 μM with a sensitivity of 0.41 μA·μM−1·cm−2 and a detection limit of 0.091 μM (S/N = 3). The linear range of UA was 2–500 μM with a sensitivity of 0.11 μA·μM−1·cm−2 and a detection limit of 0.6 μM (S/N = 3). The modified electrode exhibited advantages such as high sensitivity, a strong anti-interference capability, and good repeatability. Furthermore, the modified electrode was successfully used for DA measurement in vivo. This could present a simple reliable route for neurotransmitter detection in neuroscience.

chemistry, multidisciplinary,biochemistry & molecular biology

What problem does this paper attempt to address?

This paper aims to solve the problem of simultaneous in - vivo detection of dopamine (DA) and uric acid (UA). DA and UA play important roles in human physiological processes, and their abnormal levels may lead to various diseases, such as Parkinson's disease and gout. Since the oxidation potentials of DA and UA are very close, it is challenging to detect these two substances simultaneously. For this reason, the authors developed a method based on a three - dimensional reduced graphene oxide - MXene (3D rGO - Ti₃C₂) composite electrode, which was prepared by a simple one - step hydrothermal reduction process, can separate the oxidation potentials of DA and UA, and achieve the synchronous detection of the two. The electrode exhibits excellent electrocatalytic activity for DA and UA, has high sensitivity, strong anti - interference ability, good repeatability and stability, and has been successfully applied to the measurement of DA in vivo.